Transmedics Group Inc (NASDAQ:TMDX)
| 19.35 Delayed Data As of Jan 15 |  +0.25 / +1.31%Today’s Change | 10.10 Today|||52-Week Range 20.99 | -2.76% Year-to-Date |
Latest TMDX News | Press Releases
No recent news for Transmedics Group Inc.
Today’s Trading
| Previous close | 19.10 |
| Today’s open | 19.05 |
| Day’s range | 19.05 - 20.14 |
| Volume | 4,570 |
| Average volume (3 months) | 137,326 |
| Market cap | $525.8M |
Data as of 3:59pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | -98.35% |
| Earnings growth (this year) | +49.47% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +81.33% |
| P/E ratio | NM |
| Price/Sales | 11.19 |
| Price/Book | 7.50 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ANIKAnika Therapeutics I... | -1.79 | -4.37% |
| SPNESeaSpine Holdings Co... | -0.33 | -1.93% |
| SRDXSurmodics Inc | -1.09 | -2.40% |
| ---- |
Data as of 3:59pm ET, 01/15/2021
Financials
| Next reporting date | March 8, 2021 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $23.6M |
| Annual profit (last year) | -$33.5M |
| Net profit margin | -142.12% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Andover, Massachusetts |
Forecasts
